Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

GLP-1 receptor agonists, like Dulaglutide, Liraglutide, and Semaglutide, have potential benefits beyond the pancreas, including neuroprotection, pain suppression, cardiovascular protection, obesity management, and cancer treatment, but there are concerns about pancreatitis and pancreatic cancer risks.

Erlotinib can cause persistent excessive hair growth.

Curcumin may be an effective and safer anticancer agent by regulating key cell pathways.

A woman with cervical cancer had rare scalp metastasis causing a unique type of hair loss.

Using protein degradation to fight cancer drug resistance shows promise but needs more precise targeting and fewer side effects.

New targeted cancer drugs can cause skin side effects, and managing them requires patient education and timely care.

Patients with metastatic breast cancer treated with epirubicin and docetaxel had a good response and maintained their quality of life.

Hair loss due to scalp metastasis from breast cancer, known as Neoplastic Alopecia, has a better survival rate than other scalp metastases and requires a biopsy for diagnosis.

Nanocarriers can improve the effectiveness of herbal medicines in treating colorectal cancer.

Cinnamon bark extract may help prevent weight loss and hair loss in breast cancer patients during chemotherapy and is safe to use.

Bee venom shows promise for treating cancer, infections, inflammation, and hair loss.

Pancreatic cancer had a very low survival rate and was hard to treat effectively.

Higher cholesterol levels increase aggressive prostate cancer risk.

Dr. Mario Lacouture recommends preventive and specific treatments for skin side effects caused by EGFR inhibitors to improve patients' quality of life.

Understanding breast cancer requires considering both medical advancements and social influences.

Spironolactone is safe for breast cancer survivors with alopecia and does not increase cancer risk.

PRP hair treatment is generally safe but may cause minor pain, bleeding, redness, and scalp tightness, and isn't suitable for everyone.

A three-month treatment with a GnRH agonist significantly lowered androgen levels and 5α-reductase activity in men with benign prostatic hyperplasia.

HDR electronic brachytherapy effectively treats nonmelanoma skin cancer with good cosmetic results and minimal side effects.

Spironolactone is safe for treating female hair loss, but the safety of other drugs is uncertain.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

Doxil showed some effectiveness against advanced prostate cancer but caused severe side effects at higher doses.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

Flutamide, a medication used for excessive hair growth, can cause severe liver damage in women.

Lenvatinib and sorafenib are generally safe but need dose adjustments due to side effects.

Men who experienced baldness at age 20 may have double the risk of getting prostate cancer.

The document concludes that there are various treatments for different types of alopecia, but more research is needed for evidence-based treatments.

In Brazil in 2018, the most common skin issues were acne, photoaging, and nonmelanoma skin cancer, with treatments often including topical medications and sunscreen.

SRD5A1 is crucial in advanced prostate cancer, and blocking both SRD5A1 and SRD5A2 is more effective than targeting SRD5A2 alone.